DRMA Competitors & Alternatives
Compare Dermata Therapeutics Inc with similar stocks in the same industry
Biotechnology
DRMA
Main Stock$1.11
Tradestie Score
61
Market Cap
$3.50M
Analyst Upside
+260.4%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.07
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.84
|
$114.01M | - | 45 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$25.31
|
$110.20M | - | 65 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.89
|
$84.52M | - | 57 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.23
|
$67.94M | - | 47 | Compare |
|
PALI
Palisade Bio, Inc. Common Stock
|
$1.43
|
$12.21M | 2.2 | 53 | Compare |
|
RNAZ
TransCode Therapeutics, Inc. Common Stock
|
$1.55
|
$8.85M | - | 43 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.40
|
$7.21M | - | 53 | Compare |
|
BBLG
Bone Biologics Corp Common Stock
|
$0.48
|
$5.01M | - | 41 | Compare |
|
REVB
Revelation Biosciences, Inc. Common Stock
|
$0.80
|
$3.42M | 0.0 | 38 | Compare |
More DRMA Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry